COMPLETE BLOOD COUNT DEVICE MARKET ANALYSIS

Complete Blood Count Device Market, by Product Type (3-Part Analyzer, 5-Part Analyzer, and 6-Part Analyzer), by Modality (Portable and Stationary), by Test Type (White Blood Cell Count (WBC or leukocyte count), WBC Differential Count, Red Blood Cell Count (RBC or erythrocyte count), Hematocrit (Hct), Hemoglobin (Hbg), Platelet Count, Mean Platelet Volume (MPV), Mean Corpuscular Hemoglobin (MCH), and Others), by End User (Hospital, Diagnostic Laboratories, Research Institutes, and Others), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Mar 2022
Code : CMI4974
Pages :204
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

The increasing product launches by key players operating in the market is expected to drive the market growth over the forecast period.

For instance, in February 2021, Beckman Coulter, a medical devices company, launched DxH 560 AL, a tabletop hematology analyzer designed to reduce the time and resource constraints faced by small to mid-sized diagnostic laboratories. Moreover, the DxH 560 AL delivers results in 60 seconds or less. It can be used with difficult-to-draw patients (infants, oncology, and elderly) because it only needs a 17 μL sample less than a drop of blood.